Souhaitez-vous accéder aux communiqués récents ?

Washington, D.C., USA, April 21, 2026 (GLOBE NEWSWIRE) -- ABB’s microgrid-ready UPS architecture integrates battery storage, renewables, and gas generation for resilience and flexibility for AI data...

NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency exchange traded products (ETPs), today announced its expected distribution dates of...

Phase III METEOROID study met its primary endpoint in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)MOGAD is a rare autoimmune disease of the central nervous...

21Shares AG LEI: 254900UWHMJRRODS3Z64 21 April 2026 Publication of Base Prospectus The following Base Prospectus has been approved by the Financial Conduct Authority and is available for...

Investors can now capture rewards from the protocol commanding over 50% of DEX perpetual open interest Zurich, 21 April 2026 – 21shares, a global leader in cryptocurrency exchange-traded products...

Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a significant reduction in disease activity compared with placebo in people with systemic lupus erythematosus (SLE)If...

SIKA ERWEITERT AKTIVITÄTEN IN ZENTRALASIEN MIT NEUER LÄNDERGESELLSCHAFT IN KIRGISISTAN Sika stärkt die Position in Zentralasien mit der Gründung einer neuen Ländergesellschaft in Kirgisistan. Mit...

SIKA EXPANDS ITS ACTIVITIES IN CENTRAL ASIA WITH A NEW NATIONAL SUBSIDIARY IN KYRGYZSTAN Sika is strengthening its position in Central Asia by establishing a new national subsidiary in Kyrgyzstan....

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 21, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a...

MP0632 nominated as first logic-gated Switch-DARPin T cell engager candidate for the treatment of MSLN/EpCAM expressing solid tumors, with preclinical data indicating favorable therapeutic...